TREAT-NMD SERVICES LTD
Company number 12110979 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£522,308
Balance sheet as at 2022-07-31
Overview
- Company type
- Private Limited Company
- Incorporated
- 2019-07-18
- Employees
- 13 (2022 accounts · was 11 in 2021)
- Registered office
- C/O Womble Bond Dickinson (Uk) Llp The Spark, Draymans Way, Newcastle Helix, Newcastle Upon Tyne, England, NE4 5DE
- Postcode
- NE4 5DE
- Capital
- 5 GBP
- Accounts category
- Small
Accounts
- Last made up to
- 2024-07-31
- Next due by
- 2026-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2026-07-17
- Next due by
- 2027-07-31
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 4 current · 2 resigned
Group structure
Controlled by TREAT-NMD ALLIANCE LTD — since 2019-07-18
From persons-with-significant-control filings on the public register.
Data protection registration
Registered with the ICO as a data protection fee payer — ZB322436 (Tier 2), registered since 2022.
Information Commissioner's Office register of fee payers, licensed under the Open Government Licence.
Contact details
- Website
- treat-nmd.org
- Phone
- 0000000000000, 0008180305391, 0051209980
Previous registered addresses 1
| Address | Changed on |
|---|---|
| INSTITUTE OF GENETIC MEDICINE INTERNATIONAL CENTRE FOR LIFE, NEWCASTLE UPON TYNE, NE1 3BZ, UNITED KINGDOM | 2019-09-24 |
Among its peers
3rd largest employer
of 22 similar companies in NE, with 13 staff.
Competitors Newcastle Upon Tyne
-
5. PXD LIMITED
This company ranks 10 among research and experimental development on biotechnology in Newcastle Upon Tyne.
The class of 2019
39%
of the 500 companies in this sector incorporated in 2019 are still active today; 57% have since been dissolved.
A fact about the year, not a forecast for this company.